Proteasomal Inhibition Promotes ATP-Binding Cassette Transporter A1 (ABCA1) and ABCG1 Expression and Cholesterol Efflux From Macrophages In Vitro and In Vivo

Effect of Sulfonylurea Agents on Reverse Cholesterol Transport in Vitro and Vivo

(2011) Yoshio Terao et al.   Journal of Atherosclerosis and Thrombosis

The COP9 signalosome controls ubiquitinylation of ABCA1

(2009) Yuya Azuma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways

(2009) Melissa H. Nagelin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis

(2009) Reijiro Arakawa et al.   JOURNAL OF LIPID RESEARCH

Targeting the ubiquitin system in cancer therapy

(2009) Daniela Hoeller et al.   NATURE

Update on strategies to increase HDL quantity and function

(2009) Danielle Duffy et al.   Nature Reviews Cardiology

12/15-Lipoxygenase Activity Increases the Degradation of Macrophage ATP-Binding Cassette Transporter G1

(2008) Melissa H. Nagelin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The ubiquitin system, disease, and drug discovery

(2008) Matthew D Petroski   BMC BIOCHEMISTRY

Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis

(2008) Joerg Herrmann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Proteasome inhibitors: Poisons and remedies

(2007) Silke Meiners et al.   MEDICINAL RESEARCH REVIEWS